Access to anti-retroviral drugs, male in Italy

Italy: Access to anti-retroviral drugs, male was 85.0% in 2023. ▲ Rising

Latest (2023)
85.0%
Change on year
down 1.2%
World rank
34th
of 141 countries
All-time high
87.0%
in 2019
All-time low
31.0%
in 2000
Years of data
24
2000–2023

Access to anti-retroviral drugs, male in Italy, 2000–2023

0204060802000201120232000: 31 %2001: 36 %2002: 41 %2003: 45 %2004: 49 %2005: 52 %2006: 55 %2007: 58 %2008: 60 %2009: 63 %2010: 65 %2011: 67 %2012: 67 %2013: 70 %2014: 73 %2015: 74 %2016: 75 %2017: 79 %2018: 83 %2019: 87 %2020: 86 %2021: 86 %2022: 86 %2023: 85 %

Source: UNAIDS estimates. Measured in %.

Analysis

The most recent figure for access to anti-retroviral drugs, male in Italy is 85.0%, measured in 2023.

Compared with earlier readings it is down 1.2% on the previous year and up 21.4% over ten years.

Over the whole period, access to anti-retroviral drugs, male in Italy peaked at 87.0% in 2019 and was at its lowest, 31.0%, in 2000.

That places Italy 34th out of 141 countries with data for 2023, putting it in the top quarter.

The long-run direction has been consistently rising across the 24 years of available data.

Access to anti-retroviral drugs, male in Italy, year by year

Annual values for Access to anti-retroviral drugs, male (%) in Italy, 2000 to 2023.
Year % Change
2000 31.0%
2001 36.0% +16.1%
2002 41.0% +13.9%
2003 45.0% +9.8%
2004 49.0% +8.9%
2005 52.0% +6.1%
2006 55.0% +5.8%
2007 58.0% +5.5%
2008 60.0% +3.4%
2009 63.0% +5.0%
2010 65.0% +3.2%
2011 67.0% +3.1%
2012 67.0% +0.0%
2013 70.0% +4.5%
2014 73.0% +4.3%
2015 74.0% +1.4%
2016 75.0% +1.4%
2017 79.0% +5.3%
2018 83.0% +5.1%
2019 87.0% +4.8%
2020 86.0% -1.1%
2021 86.0% +0.0%
2022 86.0% +0.0%
2023 85.0% -1.2%

Averages by decade

DecadeAverage LowestHighest Years
2000s 49.0% 31.0% 63.0% 10
2010s 74.0% 65.0% 87.0% 10
2020s 85.8% 85.0% 86.0% 4

Countries ranked near Italy

  1. 34 New Zealand 85.0% compare
  2. 36 Croatia 84.0% compare
  3. 36 Eswatini 84.0% compare
  4. 36 Kenya 84.0% compare
  5. 36 Nigeria 84.0% compare

See the full ranking of 160 places →

More gender data for Italy

All data for Italy →

Frequently asked questions

What is access to anti-retroviral drugs, male in Italy?
Access to anti-retroviral drugs, male in Italy was 85.0% in 2023, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, male recorded in Italy?
The highest recorded value was 87.0% in 2019.
What is the lowest access to anti-retroviral drugs, male recorded in Italy?
The lowest recorded value was 31.0% in 2000.
How does Italy rank for access to anti-retroviral drugs, male?
Italy ranks 34th out of 141 countries with data for 2023.
Is access to anti-retroviral drugs, male rising or falling in Italy?
Over the last ten years it is up 21.4%. The long-run trend across the full record is rising.
Where does this Italy data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, male in Italy. Statizoid, drawing on UNAIDS estimates. Retrieved 10 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/italy/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-male-percent/italy/">Access to anti-retroviral drugs, male in Italy</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, male (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,923 data points, 2000–2024
Last refreshed

The percentage of adult males living with HIV who are receiving antiretroviral therapy.